Cargando…
Three cases of BRAF-mutant melanoma with divergent differentiation masquerading as sarcoma
Melanoma is an important cause of skin cancer related death throughout the world, particularly in Europe, the United States, and Australia. Rarely melanoma undergoes divergent differentiation to simulate the full morphologic and immunohistochemical features of other malignancies, notably sarcoma. Ho...
Autores principales: | Cilento, Michael A., Kim, Chankyung, Chang, Sean, Farshid, Gelareh, Brown, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248244/ https://www.ncbi.nlm.nih.gov/pubmed/35775707 http://dx.doi.org/10.32074/1591-951X-771 |
Ejemplares similares
-
Dabrafenib for treatment of BRAF-mutant melanoma
por: Kainthla, Radhika, et al.
Publicado: (2013) -
Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
por: Kim, Jae-Hyeon, et al.
Publicado: (2017) -
Optimizing the treatment of BRAF mutant melanoma
por: Settleman, Jeff
Publicado: (2014) -
BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016) -
Variations of BRAF mutant allele percentage in melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2015)